Verge Genomics

Jobs at Verge Genomics

Faster cures using genomics (YC S15)

Currently, it takes 12 years and $2.6 billion to get a single drug to market, with the drug discovery and development process costing $1.4 billion. Verge Genomics recently raised $32 million in Series A financing to change this broken model by fueling the drug discovery pipeline with machine learning. Read More
Apply Now

What We're Building

Verge Genomics is a next-generation drug discovery company that is using human genomic data to defeat neurodegeneration. In just the last year, we have built the field's largest human brain genomic database, closed two pharma partnerships, and made important breakthroughs on two novel therapeutic targets in ALS patient neurons.

Founded by scientists from leading neuro-genomics labs, the Verge team is 14 people including 12 Ph.D.s in machine learning, neuroscience, applied math, biophysics, statistics, and computational biology from UCLA, Stanford, Oxford, and UCSF, two former professors, and two pharma veterans who have taken drugs from idea to clinic (including a leading schizophrenia drug in market and a non-addictive pain opiate).

Jobs at Verge Genomics

Verge Genomics Team

Lucia Huang
Director of Operations and Finance at Verge Genomics (YCS15). Previously investor in growth stage healthcare companies at Warburg Pincus. Yale '14 Chemistry.

Verge Genomics Investors

Henry McNamara
Partner @Great Oaks Venture Capital • Marketplaces, Consumer, B2B, Health • @New York City
Andrew Jiang
Alum of @Y Combinator, @Sprig, @BCG, and NYU
Dave Morin
Kevin Colleran
Managing Director @Slow Ventures focused on early stage technology investing. Previously one of the first 10 employees @Facebook.
See More

People also viewed

Redwood City
San Francisco, New York City
San Francisco, Minneapolis
Foster City
San Francisco
Santa Clara
San Francisco
San Francisco